326 related articles for article (PubMed ID: 25339736)
1. Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.
Wu F; Catano M; Echeverry R; Torre E; Haile WB; An J; Chen C; Cheng L; Nicholson A; Tong FC; Park J; Yepes M
J Neurosci; 2014 Oct; 34(43):14219-32. PubMed ID: 25339736
[TBL] [Abstract][Full Text] [Related]
2. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.
Diaz A; Merino P; Manrique LG; Cheng L; Yepes M
J Cereb Blood Flow Metab; 2019 Nov; 39(11):2157-2171. PubMed ID: 29890880
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain.
Merino P; Yepes M
J Neurol Exp Neurosci; 2018; 4(2):24-29. PubMed ID: 30417161
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain.
Yepes M
Neural Regen Res; 2020 Apr; 15(4):620-624. PubMed ID: 31638083
[TBL] [Abstract][Full Text] [Related]
8. The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain.
Yepes M
Curr Drug Targets; 2019; 20(9):953-959. PubMed ID: 30539695
[TBL] [Abstract][Full Text] [Related]
9. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
Lugano R; Peña E; Badimon L; Padró T
J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator promotes recovery following spinal cord injury.
Seeds N; Mikesell S; Vest R; Bugge T; Schaller K; Minor K
Cell Mol Neurobiol; 2011 Aug; 31(6):961-7. PubMed ID: 21573723
[TBL] [Abstract][Full Text] [Related]
11. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
[TBL] [Abstract][Full Text] [Related]
12. The Plasminogen Activation System Promotes Dendritic Spine Recovery and Improvement in Neurological Function After an Ischemic Stroke.
Jeanneret V; Yepes M
Transl Stroke Res; 2016 Feb; ():. PubMed ID: 26846991
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke.
Nagai N; Okada K; Kawao N; Ishida C; Ueshima S; Collen D; Matsuo O
Neurosci Lett; 2008 Feb; 432(1):46-9. PubMed ID: 18164548
[TBL] [Abstract][Full Text] [Related]
14. Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.
Cunningham O; Campion S; Perry VH; Murray C; Sidenius N; Docagne F; Cunningham C
Glia; 2009 Dec; 57(16):1802-14. PubMed ID: 19459212
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.
Diaz A; Merino P; Guo JD; Yepes MA; McCann P; Katta T; Tong EM; Torre E; Rangaraju S; Yepes M
J Neurosci; 2020 May; 40(21):4251-4263. PubMed ID: 32332118
[TBL] [Abstract][Full Text] [Related]
16. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
[TBL] [Abstract][Full Text] [Related]
17. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
18. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
19. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapse.
Merino P; Diaz A; Torre ER; Yepes M
J Biol Chem; 2020 Jan; 295(2):619-630. PubMed ID: 31819012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
